Flagship Pioneering, LLC

Q2 2021 13F Holdings Report, Stock Holdings

Notable people
Ph.D. Noubar B. Afeyan
Signature - Title
Noubar B. Afeyan, Ph.D. - Chief Executive Officer
Location
Cambridge, MA
Holdings as of
30 Jun 2021
Value $
$0
Num holdings
12
Filing time
16 Aug 2021, 08:59:05 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included .
Previous filing
Q1 2021 - 17 May 2021
Next filing
Q3 2021 - 15 Nov 2021
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q2 compared to 2021 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Noubar B. Afeyan, Ph.D. Chief Executive Officer Cambridge, Massachusetts 16 Aug 2021

Other Included Managers (7):

Num Name Location File Number
1 Flagship Ventures Fund V General Partner LLC Cambridge, MA 028-18466
2 Flagship Ventures Fund IV General Partner LLC Cambridge, MA 028-17238
3 Ph.D. Noubar B. Afeyan Cambridge, MA 028-19988
4 Flagship Ventures Opportunities Fund I General Partner LLC Cambridge, MA 028-20999
5 Flagship Pioneering Special Opportunities Fund II General Partner LLC Cambridge, MA 028-20997
6 Nutritional Health LTP Fund General Partner LLC Cambridge, MA 028-21001
7 Flagship Pioneering Fund VI General Partner LLC Cambridge, MA 028-20998